Get 40% Off
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas toolCopy Portfolios

Helen Of Troy's Oxo Brand To Develop New Injection Device

Published 10/25/2016, 04:29 AM
Updated 07/09/2023, 06:31 AM
AVP
-
PG
-
HELE
-
NUS
-

Consumer products company Helen of Troy Limited (NASDAQ:HELE) is all set to boost its presence in the health and wellness business. As a part of this strategy, Helen of Troy’s brand Oxo in partnership with Brussels, Belgium-based biopharmaceutical company UCB, develop new certolizumab pegol (Cimzia) AutoClicks Prefilled Pen in the National Health Services (NHS), UK.

These prefilled pens can be administered to cure diseases like rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis and axial spondyloarthritis. The validation for the use of these pens as injections was given by the European Medicine's Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP).

The injections are extremely user-friendly and are specially designed keeping the hand disability of the patients in mind. Further, these feature a wide grip and a button-free delivery system that is beneficial for the patients. It has a large viewing window which enables patients to know about the start and the completion of the injection simply with double clicks. This ensures patients get the full dose of their medicine. The injections come at a monthly £715 (2 treatments doses of 200mg) for a patient.

Oxo brand, taken over by Helen of Troy in 2004, forms a part of the latter’s Housewares segment. Oxo’s products include kitchen tools, cutlery, bar and wine accessories as well as household cleaning tools, food storage containers and tea kettles. It products also include trash cans, storage and organization products, hand tools, gardening tools, kitchen mitts and trivets, barbecue tools and baby and toddler care products. The OXO brand is widely known for its user-friendly consumer products.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Recently, in Mar 2016, Helen of Troy reinforced its Housewares segment by the takeover of the brand Hydro Flask and all membership units of Steel Technology, LLC in a cash deal worth $210 million. Apart from this, the company took over the Vicks Vaposteam business from the Procter & Gamble Company (NYSE:PG) in Mar 2015 following its venture into vitamin supplements space with the Healthy Directions buyout in 2014.

Zacks Rank

Helen of Troy carries a Zacks Rank #4 (Sell).

Better ranked stocks in the cosmetics and toiletries sector include Avon Products Inc. (NYSE:AVP) and Nu Skin Enterprises Inc. (NYSE:NUS) .

Avon Products Inc. carries a Zacls Rank #1 (Strong Buy) and carries a long term growth rate of 5%. You can see the complete list of today’s Zacks #1 Rank stocks here.

Nu Skin Enterprises Inc. carries a Zacks Rank #2 (Buy) and has a long-term growth rate of 7.8%.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



AVON PRODS INC (AVP): Free Stock Analysis Report

NU SKIN ENTERP (NUS): Free Stock Analysis Report

HELEN OF TROY (HELE): Free Stock Analysis Report

PROCTER & GAMBL (PG): Free Stock Analysis Report

Original post

Zacks Investment Research
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.